Site updated at Wednesday, 22 June 2016

Living with Dementia

Alzheimer Treatment

India’s Piramal buys Bayer’s potential Alzheimer drug

Indian drugmaker Piramal Healthcare has agreed to buy a research and development portfolio from Bayer AG, the company said, in a deal that gives Piramal rights to florbetaben, a possible Alzheimer treatment.

Florbetaben, which is in the final stages of clinical trials, works by detecting symptoms in probable sufferers of Alzheimer’s, and is expected… India’s Piramal buys Bayer’s potential Alzheimer drug   

Living with dementia

neuronal degeneration1 - developing alzheimers2 - university of southern california2 - cancer1 - blood vessels1 - statins1 - sporadic parkinson's disease1 - diet high in carbohydrates1 - mentally weak1 - brain changes1 - degree of dementia1 - alzheimer's drug5 - stroke risk factors1 - alzheimer's imaging agents1 - wernicke's disease10 - risk of parkinson's1 - lou gehrig's disease1 - vascular dementia13 - aging5 - apolipoprotein1 - stroke risk1 - citalopram2 - alzheimer's disease symptoms1 - symptoms of dementia3 - eeg1 - mental confusion4 - deep-brain stimulation3 - virtual reality1 - agitation2 - against alzheimer's1 -